drugset / Trial / NCT05468060
Study of the Safety, Tolerability, Pharmacokinetic Characteristics of PA1010 in Healthy Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
The primary objectives of this study are to evaluate the safety, tolerability and pharmacokinetics characteristics of single ascending dose (SAD) of PA1010 tablets in Chinese healthy adults and the impact of food and gender on the pharmacokinetics
Timeline
- Start
- 2020-06-28
- Primary completion
- 2020-12-12
- Completion
- 2020-12-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PA1010 | Unknown | 5 mg | — |
| Subject | PA1010 | Unknown | 10 mg | — |
| Subject | PA1010 | Unknown | 20 mg | — |
| Subject | PA1010 | Unknown | 30 mg | — |
| Subject | PA1010 | Unknown | 45 mg | — |
| Subject | PA1010 | Unknown | 60 mg | — |